A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 1499
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : LTBI
Long Form : latent tuberculosis infection
No. Year Title Co-occurring Abbreviation
2022 Analysis of Some Risk Factors of Active Tuberculosis in Three South Florida Counties. HIV, RVCT, TB
2022 Machine learning based on routine laboratory indicators promoting the discrimination between active tuberculosis and latent tuberculosis infection. ATB
2022 Whole-blood 3-gene Signature as a Decision Aid for Rifapentine-based TB Preventive Therapy. RT-qPCR, SDR, SHAP
2021 A 55-Year-Old Japanese Man with Multiple Sclerosis Diagnosed with Disseminated Tuberculosis Identified by Liver Function Abnormalities: A Case Report. ---
2021 A cross-sectional study of latent tuberculosis infection, insurance coverage, and usual sources of health care among non-US-born persons in the United States. CI, IGRA, NHANES, TB, US
2021 A Survey of Latent Tuberculosis Screening and Treatment Practices in a Tertiary Centre. IGRA
2021 Acquired Resistance to Isoniazid During Isoniazid Monotherapy in a Subject with Latent Infection Following Household Rifampicin-Resistant Tuberculosis Contact: A Case Report. TB
2021 Activation Phenotype of Mycobacterium tuberculosis-Specific CD4+ T Cells Promoting the Discrimination Between Active Tuberculosis and Latent Tuberculosis Infection. ATB, Mtb
2021 Active and latent tuberculosis infections in patients treated with immune checkpoint inhibitors in a non-endemic tuberculosis area. ICIs, IGRA, TB
10  2021 An investigation of tuberculosis progression revealing the role of macrophages apoptosis via sensitivity and bifurcation analysis. ---
11  2021 An observational study on prevalence of latent tuberculosis infection and outcome of 3HP treatment in patients under hemodialysis in Taiwan. IGRA, TB
12  2021 Analysis of 605 tuberculosis outbreaks in Japan, 1993-2015: time, place and transmission site. TB
13  2021 Are patients with rheumatic diseases on immunosuppressive therapies protected against preventable infections? A cross-sectional cohort study. bDMARDs, CIRD, HepB
14  2021 Artificial neural network to predict the effect of obesity on the risk of tuberculosis infection. ANN, AUC, CI, NHANES, OR
15  2021 Association between latent tuberculosis and ischemic heart disease: a hospital-based cross-sectional study from Saudi Arabia. CAA, DM, IHD, MDCT-CA, QFT, TB
16  2021 Association of TAP1 1177A>G and 2090A>G gene polymorphisms with latent tuberculosis infections in sheltered populations, in the metropolitan area of Guadalajara, Mexico: a pilot study. ---
17  2021 Bovine ownership and reduced pulmonary tuberculosis risk in Nepal: A case-control study. BCG, PTB
18  2021 Combination of Blood Routine Examination and T-SPOT.TB Assay for Distinguishing Between Active Tuberculosis and Latent Tuberculosis Infection. ATB, AUC, BRE, SFC
19  2021 Comparative Efficacy of Rifapentine Alone and in Combination with Isoniazid for Latent Tuberculosis Infection: a Translational Pharmacokinetic-Pharmacodynamic Modeling Study. 6wP
20  2021 Comparing the cost-effectiveness of two screening strategies for latent tuberculosis infection in Portugal. ICER, IGRA, TST
21  2021 Comparison of Interferon-Gamma Release Assay and Tuberculin Skin Test for the Screening of Latent Tuberculosis in Inflammatory Bowel Disease Patients: Indian Scenario. IBD, IGRA, TST
22  2021 Cost effectiveness of three months of rifapentine and isoniazid for latent tuberculosis in Syrian refugees. QALYs
23  2021 Cost-effectiveness of the latent tuberculosis screening program for migrants in Stockholm Region. ICER, QALY, SEK, TB
24  2021 Cross-sectional study of prevalence and risk factors, and a cost-effectiveness evaluation of screening and preventive treatment strategies for latent tuberculosis among migrants in Singapore. ICERs, IGRA, QALYs
25  2021 Cytokine and Chemokine mRNA Expressions after Mycobacterium tuberculosis-Specific Antigen Stimulation in Whole Blood from Hemodialysis Patients with Latent Tuberculosis Infection. HD, HD/LTBI, mRNA, Mtb, QFT-GIT
26  2021 Decreased annual risk of tuberculosis infection in South Korean healthcare workers using interferon-gamma release assay between 1986 and 2005. ARI, HCWs, IGRA, TB
27  2021 Defective expansion and function of memory like natural killer cells in HIV+ individuals with latent tuberculosis infection. TB
28  2021 Determinants of latent tuberculosis infection and treatment interruption in long-term care facilities: A retrospective cohort study in Taiwan. aOR, CI, DOPT, LTCFs
29  2021 Determinants of losses in the latent tuberculosis infection cascade of care in Brazil. IGRA, TB, TPT
30  2021 Diabetes-Associated Susceptibility to Tuberculosis: Contribution of Hyperglycemia vs. Dyslipidemia. TB
31  2021 Diagnosis of latent tuberculosis among HIV infected patients in Ilorin, Nigeria using tuberculin skin test and interferon gamma release assay. HAART, IGRA, TST, UITH
32  2021 Diagnosis of latent tuberculosis infection among pediatric household contacts of Iranian tuberculosis cases using tuberculin skin test, IFN- gamma release assay and IFN-gamma-induced protein-10. IP-10, QFT-Plus, TB, TST
33  2021 Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis. INF-gamma, QFT, TB, TST
34  2021 Disseminated Tuberculosis Associated With Adalimumab Therapy. TB
35  2021 Disseminated Tuberculosis in a Psoriasis Patient under Adalimumab Treatment despite the Chemoprophylaxis of Latent Tuberculosis: A Case Report. CT, IL, TB
36  2021 Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trial. ---
37  2021 Emergency department screening for latent tuberculosis infection. ED, QFT
38  2021 Evaluation of a lateral flow assay-based IFN-gamma release assay as a point-of-care test for the diagnosis of latent tuberculosis infection. IMID, QFT-PLUS
39  2021 Evaluation of a new interferon gamma release assay, in comparison to tuberculin skin tests and quantiferon tuberculosis goldplus for the detection of latent tuberculosis infection in children from a high tuberculosis burden setting. IGRA, QFT-Plus, TB, TBF, TST
40  2021 Evaluation of the Fully Automated Chemiluminescence Analyzer Liaison XL for the Performance of the QuantiFERON-TB Gold Plus Assay in an Area with a Low Incidence of Tuberculosis. CLIA, ELISAs, IFN-gamma, QFT-Plus
41  2021 Evaluation of the performance of QuantiFERON-TB Gold plus test in active tuberculosis patients. QFT-Plus
42  2021 Factors influencing the initiation and adherence of LTBI treatment in healthcare workers: a systematic review. HCWs
43  2021 Fewer losses in the cascade of care for latent tuberculosis with solo interferon-gamma release assay screening compared to sequential screening. IGRA, TB, TST
44  2021 Four months of rifampicin monotherapy for latent tuberculosis infection in children. ---
45  2021 Frequency of Positive Conversion of Interferon-Gamma Release Assay Results Among Patients With Inflammatory Bowel Disease Treated With Non-tumor Necrosis Factor Inhibitors. IBD, IGRA
46  2021 Functional Polymorphism in the NFE2L2 Gene Associated With Tuberculosis Susceptibility. Nrf2, TB
47  2021 Health of Asylees Compared to Refugees in the United States Using Domestic Medical Examination Data, 2014-2016: A Cross-Sectional Analysis. PR
48  2021 Host transcriptional response to TB preventive therapy differentiates two sub-groups of IGRA-positive individuals. IGRA, Mtb, PT
49  2021 Immune Subtyping in Latent Tuberculosis. TB
50  2021 Impact of latent tuberculosis infection on health and wellbeing: a systematic review and meta-analysis. HRQoL, TB
51  2021 Impact of Latent Tuberculosis on Severity and Outcomes in Admitted COVID-19 Patients. BCG, COVID-19, NL, TST
52  2021 Incidence and Risk Factors Associated with Latent Tuberculosis Infection and Pulmonary Tuberculosis among People Deprived of Liberty in Colombian Prisons. PDL, TB, TST
53  2021 Infectious disease consultation is effective in boosting vaccine coverage in patients awaiting kidney transplantation: A French prospective study. IGRA
54  2021 Infectious diseases screening approach among refugees: results from a single-center study. BBV, STDs, TB, XRC
55  2021 Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis. ---
56  2021 Latent and active tuberculosis infection in allogeneic hematopoietic stem cell transplant recipients: a prospective cohort study. HSCT, IGRA, QTF-GIT, TB, TST
57  2021 Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection. ---
58  2021 Latent Tuberculosis in Psoriasis Patients Planned for Systemic Therapy - A Prospective Observational Study. TST
59  2021 Latent tuberculosis infection (LTBI): What happens at 5 years of the 155 LTBI recent contacts of tuberculosis with positive microscopic examination? ---
60  2021 Latent Tuberculosis Infection among Health Workers in Germany-A Retrospective Study on Progression Risk and Use of Preventive Therapy. HW, TB, TPT
61  2021 Latent tuberculosis infection in medical students in the Northeast of Mexico. PPE
62  2021 Latent tuberculosis infection prevalence in second generation immigrants from high to low TB burden countries. TB, TST
63  2021 Latent tuberculosis infection reactivation in patients with multiple sclerosis in use of disease-modifying therapies: A systematic review. CNS, DMTs, MS, TB
64  2021 Latent Tuberculosis Infection Screening and Treatment in Congregate Settings (TB FREE COREA): Demographic Profiles of Interferon-Gamma Release Assay Cohort. IGRA
65  2021 Latent Tuberculosis Infection Status of Pregnant Women in Uganda Determined Using QuantiFERON TB Gold-Plus. aOR, CI, HIV, QFT-plus, TB
66  2021 Latent Tuberculosis Infection Testing and Treatment at a Federally Qualified Health Center in Southern California: A Quality Improvement Project. TB
67  2021 Latent tuberculosis infection: Misperceptions among non-U.S.-born-populations from countries where tuberculosis is common. BCG, TB
68  2021 Latent tuberculosis screening before kidney transplantation in the South of Brazil. IGRAs, KT, LD, QFT, TB, TST
69  2021 Lessons Learned from Implementation of an Interferon Gamma Release Assay to Screen for Latent Tuberculosis Infection in a Large Multicenter Observational Cohort Study in Brazil. IGRA, QFT-Plus, RePORT, TB, TST, WHO
70  2021 LINC00870 regulates Th1/Th2 via the JAK/STAT pathway in peripheral blood mononuclear cells infected with Mycobacterium tuberculosis. Mtb, PBMCs, TB
71  2021 Low uptake of isoniazid window prophylaxis in patients exposed to a health-care worker with pulmonary tuberculosis in a paediatric ward. TST, WP
72  2021 Lymphocyte-Related Immunological Indicators for Stratifying Mycobacterium tuberculosis Infection. ATB, AUC, HC, Mtb
73  2021 Malignant Peritoneal Mesothelioma with Latent Tuberculosis Infection. IGRA, MPM
74  2021 Management of childhood and adolescent latent tuberculous infection (LTBI) in Germany, Austria and Switzerland. IGRA, TB, TST
75  2021 Multifunctional T cell response in active pulmonary tuberculosis patients. APTB, CPTB, HCs
76  2021 Mycobacterial heparin-binding hemagglutinin (HBHA)-induced interferon-gamma release assay (IGRA) for discrimination of latent and active tuberculosis: A systematic review and meta-analysis. ATB, AUC, DOR, HBHA, IGRA, LR, NLR, PLR, SROC
77  2021 Mycobacterium tuberculosis in solid organ transplant donors and recipients. SOT, TB
78  2021 Mycobacterium tuberculosis latency-associated antigen Rv1733c SLP improves the accuracy of differential diagnosis of active tuberculosis and latent tuberculosis infection. ATB, CFP-10, ESAT-6, FluoroSpot, IFN-gamma, IL-2, Mtb, ROC, SFCs
79  2021 Mycobacterium tuberculosis-derived circulating cell-free DNA in patients with pulmonary tuberculosis and persons with latent tuberculosis infection. cfDNA, MLR, Mtb, PTB, qPCR
80  2021 Mycobacterium tuberculosis-specific T cell responses are impaired during late pregnancy with elevated biomarkers of tuberculosis risk postpartum. Mtb, TB
81  2021 Obesity and Prevalence of Latent Tuberculosis: A Population-Based Survey. BMI, NHANES, TB
82  2021 Patterns of T and B cell responses to Mycobacterium tuberculosis membrane-associated antigens and their relationship with disease activity in rheumatoid arthritis patients with latent tuberculosis infection. Acr, Mtb, RA, TST
83  2021 Performance of 4 methods for screening of latent tuberculosis infection in patients with chronic inflammatory arthritis under TNFalpha inhibitors: a 24-month prospective study. AS, CIA, IGRAs, JIA, PsA, QFT-IT, RA, T-SPOT.TB, TNFi, TST
84  2021 Prevalence and risk factors associated with latent tuberculosis infection among household contacts of smear positive pulmonary tuberculosis patients in South India. CI, HHC, IC
85  2021 Prevalence and risk factors for latent tuberculosis in polish healthcare workers: the comparison of tuberculin skin test and interferon-gamma release assay (IGRA) performance. HCW, IGRA, IGRAs, TB, TST
86  2021 Prevalence and Risk Factors of Latent Tuberculosis Infection (LTBI) in Patients with Type 2 Diabetes Mellitus (T2DM). aOR, CIs, T2DM, TB
87  2021 Prevalence of Latent TB and Effectiveness of BCG Vaccination Against Latent Tuberculosis: An Observational Study. BCG, TST
88  2021 Prevalence of latent tuberculosis before biotherapy initiation in rheumatoid arthritis and spondyloarthritis: data from the Moroccan biotherapy registry. RA, SpA
89  2021 Prevalence of Latent Tuberculosis in the Multiple Sclerosis Clinic and Effect of Multiple Sclerosis Treatment on Tuberculosis Testing. MS, QFT-GIT, TB
90  2021 Prevalence of latent tuberculosis infection among health workers in Afghanistan: A cross-sectional study. ---
91  2021 Prevalence of Latent Tuberculosis Infection Among Healthy Young Children and Adolescents and a Two-step Approach for the Diagnosis of Tuberculosis Infection in Chengdu, China. IGRA, TST
92  2021 Prevalence of Latent Tuberculosis Infection Among Persons with Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-Analysis. HBV, TB
93  2021 Prevalence of latent tuberculosis infection and its risk factors in Japanese hemodialysis patients. HD, IGRA, TB
94  2021 Prevalence of Latent Tuberculosis Infection in the Middle East and North Africa: A Systematic Review. CI, MENA
95  2021 Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania. ARTI, ESAT-6 free IGRA, POI, QFT-GIT, TB
96  2021 Protective efficacy of 6-week regimen for latent tuberculosis infection treatment in rural China: 5-year follow-up of a randomised controlled trial. aHR, CI, TB
97  2021 Proteomic analysis of drug-susceptible and multidrug-resistant nonreplicating Beijing strains of Mycobacterium tuberculosis cultured in vitro. BJ, MDR-BJ, Mtb, TB
98  2021 Quantifying the rates of late reactivation tuberculosis: a systematic review. ---
99  2021 Rate of History of Tuberculosis Among Healthcare Workers in Turkey: A Cross-Sectional Study. BCG, BMI, HCWs, TB, TST
100  2021 Reactivation of latent tuberculosis through modulation of resuscitation promoting factors by diabetes. CFU, RIF, rpfA-E